Viewing Study NCT07366658


Ignite Creation Date: 2026-03-26 @ 3:18 PM
Ignite Modification Date: 2026-03-30 @ 4:21 AM
Study NCT ID: NCT07366658
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-01-26
First Post: 2026-01-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability and Preliminary Efficacy of NEUK203-13 in Refractory Neuroendocrine Tumor Patients
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module